Latest Breaking News On - Sud agarwal - Page 1 : comparemela.com

Appointment of Phase I Clinical Trial CRO | Company Announcement

Investegate announcements from Appointment of Phase I Clinical Trial CRO

United kingdomClarissa sowemimo cokerSimon nayyarRichard hutchisonArthur dingemansAcuitas communicationsOxford cannabinoid technologies holdingsVictoria pty ltdPty ltdOxford cannabinoid technologies holdings plcCanopy growth corporationAxis capital marketsDirectors of the companyOxford cannabinoid technologies ltdEuropean union withdrawalPhasei clinical trial

Incannex Healthcare - IHL(ASX) News & Expert Insights from Stockhead

Incannex Healthcare - IHL(ASX) News & Expert Insights from Stockhead
stockhead.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stockhead.com.au Daily Mail and Mail on Sunday newspapers.

Western australiaTroy valentinePeter widdowsGlenn fowlesJoel lathamHartley poyntonCannvalate pty ltdWorld cannabis congressCompany secretaryCann groupContango asset management ltdHj heinz company australiaHj heinz corporationPatersons securitiesAlignment capitalManaging director

Hinto Energy, Inc : Hinto Energy Acquires Novel Fibromyalgia Treatment IP

SHERIDAN, WY / ACCESSWIRE / March 14, 2023 / HINTO ENERGY, INC. (OTC:HENI) today announced a transaction, dated March 6, 2023 to acquire certain assets related to a development stage, novel treatment for

New yorkUnited statesNew south walesDennis riedlDavid conklingAndrew salzmanHinto energyHinto energy incSud agarwal at ingenue pty ltdHinto energy inc viewJf biopharma incSalzman groupSecurities exchangeBusiness developmentPharma incChief scientist

Psyence Signs Letter of Intent with Australian CRO iNGENū

VANCOUVER, British Columbia, Jan. 08, 2023 (GLOBE NEWSWIRE) Psyence Group Inc (CSE:PSYG | OTCQB: PSYGF), a life science biotechnology company.

United statesUnited kingdomBritish columbiaKatherine murphyNeil mareskyPty ltdContract research organizationPsyence group incCanadian securities exchangePsyence biomed divisionContract research organisationChief executive officerSud agarwalPsyence groupPsyence productionPsyence therapeutics

Lobe Sciences Enters into an Exclusive Agreement With iNGENu to Conduct Clinical Trials in Australia

Lobe Sciences Enters into an Exclusive Agreement With iNGENu to Conduct Clinical Trials in Australia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomBritish columbiaPhilip youngPhilipj youngLobe sciences ltdContract research organizationNgenk pty ltdLobe sciencesNgenk the australian federal government research developmentBritish columbia newsfile corpWall streetCanadian biopharmaceuticalCentral nervous systemSud agarwalAustralian federal governmentAustralian government